KAITLEN HORNBECK: Open Payments
NPI 1295327450 · EL DORADO, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,070 in 103 payments from 32 companies in 2025. Trend: 2023 $1,313 · 2024 $2,308 · 2025 $2,070
Food & beverage: $1,867Education: $203
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $391 |
| Janssen Biotech, Inc. | 11 | $210 |
| PFIZER INC. | 11 | $161 |
| Daiichi Sankyo Inc. | 5 | $155 |
| Novartis Pharmaceuticals Corporation | 6 | $104 |
| Genentech USA, Inc. | 5 | $94 |
| GlaxoSmithKline, LLC. | 5 | $91 |
| ABBVIE INC. | 4 | $73 |
| Astellas Pharma US Inc | 4 | $71 |
| Exelixis Inc. | 3 | $69 |
Products named: Enhertu, IMFINZI, Xtandi, RYBREVANT, CABOMETYX, KEYTRUDA, KISQALI, Doptelet.
Industry payments across KS — which companies pay providers there.
